Latest News
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
141 -
Did you like reading this story? Click the heart to show your love.
93
-
Did you like reading this story? Click the heart to show your love.
58
Did you like reading this story? Click the heart to show your love.
1120
Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.
More from Johnson & Johnson
June 09, 2021
Johnson & Johnson's 2020 Health for Humanity Report details the progress it's made in the past five years in driving sustainable social, environmental and economic change around the globe. Now the company's looking ahead to the next five.
April 27, 2021
The company is honored to be recognized for its leadership in helping shape the trajectory of healthcare around the world.
April 20, 2021
Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
